Local Institution - 0175

Beijing, Beijing Municipality 100142

1 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) — Recruiting now
• A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma — Running, not enrolling